July 14, 2016

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) appreciates the work of the House and Senate on passage of prescription drug abuse legislation, the Comprehensive Addiction and Recovery Act (CARA), which will allow for the creation of a “Lock-In” program in Medicare Part D for controlled substances.

A “Lock-In” program will help prevent inappropriate prescriptions from crossing the pharmacy counter by allowing Part D plans to require those at-risk of abusing prescription drugs to work with their plans to choose a single pharmacy to dispense certain medications, such as opioids.

“This legislation will help save lives. The key to curbing ‘drugstore shopping’ for controlled substances is to stop improper prescriptions from being filled at the pharmacy counter in the first place,” said PCMA President and CEO Mark Merritt.

The original legislation was introduced by Senators Pat Toomey (R-PA), Rob Portman (R-OH), Sherrod Brown (D-OH) and Tim Kaine (D-VA) and Representatives Gus Bilirakis (R-FL) and Ben Ray Luján (D-NM).